1. Home

We will be presenting at the 12th Global Drug Delivery & Formulation Virtual Summit 2021: 17th March 2021

Garry will be presenting an oral presentation, entitled Peptide Nanomaterials: The Future of Biomaterials and Drug Delivery, at 12th Global Drug Delivery & Formulation Virtual Summit 2021: Wednesday 17th March 2021 (11.50am Technology & Innovation case study section).

 

Hopefully you will have to opportunity look see our latest work within drug delivery!

Further details on the conference itself can be found by clicking the link below:

12th Global Drug Delivery & Formulation Virtual Summit 2021

Related News


Advanced Science News Coverage and Advanced Healthcare Materials paper

Our recent research into using peptide hydrogels as long-acting injectable implants for HIV/AIDS drug delivery has be covered by Advanced Science News. This provides an oversight of our most recent publication within Advanced Healthcare Materials. A link to both can be found below: Advanced Science News Advanced Healthcare Materials    

Our EPSRC research selected as case study

Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]

PhD positions available within our group: 7th January 2019 deadline

A number of PhD positions are available within the group. Funding will be allocated to successful applicants rather, than project. Successful applicant will receive tuition fees(UK/EU) paid and a stipend (for UK residents only). Closing date for all applications is 7th January 2019 with interviews being scheduled for February 2019.   Dr Garry Laverty (First […]

We will be presenting at the Controlled Release Society 2020 Virtual Meeting!

Whilst we were looking forward to the opportunity to attend CRS 2020 in Las Vegas, the ongoing pandemic has meant that we have had to cancel our travel plans.   However, we are excited to support the Controlled Release Society take part in this innovative virtual CRS initiative.   We will be presenting the following […]

Funding for Medical Research Council: Confidence in Concept Project

We are happy to announce our group has received funding as part of the MRC CiC programme (£67,867) to study the use of antiretroviral drugs in HIV/AIDs prevention alongside our industry partners. Funding will enable a Research Fellow to work within our group on this project for one year. We should hopefully be in a […]

OUR RESEARCH IS FUNDED BY

Contact Us
  • +44 (0) 28 9097 2273
  • garry.laverty@qub.ac.uk
  • School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, Co. Antrim, N.Ireland. BT97BL
  • Get Directions
Quick Links
Laverty Lab